Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Herantis Pharma Oyj

HRTIS
Current price
1.3 EUR +0.055 EUR (+4.42%)
Last closed 1.25 EUR
ISIN FI4000087861
Sector Healthcare
Industry Biotechnology
Exchange Helsinki Exchange
Capitalization 25 190 252 EUR
Yield for 12 month -23.53 %
1Y
3Y
5Y
10Y
15Y
HRTIS
21.11.2021 - 28.11.2021

Herantis Pharma Oyj, a biotech company, engages in the development of disease-modifying cerebral dopamine neurotrophic factor (CDNF) based therapies for Parkinson's disease (PD). Its lead product in pipeline includes HER-096, an advanced small synthetic chemical peptidomimetic molecule developed based on the active site of the CDNF protein for the treatment of PD and other neurodegenerative diseases. The company was incorporated in 2008 and is based in Espoo, Finland. Address: Bertel Jungin Aukio 1, Espoo, Finland, 02600

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

1.41 EUR

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures HRTIS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -8 021 479 EUR
Operating Margin TTM -279.23 %
PE Ratio
Return On Assets TTM -2.75 %
PEG Ratio
Return On Equity TTM -661.8 %
Wall Street Target Price 1.41 EUR
Revenue TTM 709 540 EUR
Book Value 0.1 EUR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 76.3 %
Dividend Yield
Gross Profit TTM 135 485 EUR
Earnings per share
Diluted Eps TTM
Most Recent Quarter II 2023
Quarterly Earnings Growth YOY
Profit Margin -86.59 %

Dividend Analytics HRTIS

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History HRTIS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1737:1652
Payout Ratio
Last Split Date 04.05.2022
Dividend Date

Stock Valuation HRTIS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM 35.5022
Enterprise Value EBITDA 79.0627
Price Book MRQ 12.31

Financials HRTIS

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators HRTIS

For 52 weeks

1.17 EUR 1.89 EUR
50 Day MA 1.45 EUR
Shares Short Prior Month
200 Day MA 1.48 EUR
Short Ratio
Shares Short
Short Percent